3 unknown, 1 completed, 1 enrolling by invitation, 1 not yet recruiting. 4 Phase 3, 3 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 2, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 3 | Unknown 2, Enrolling by invitation 1 |
| Phase 4 | 1 | Completed 1 |
Follow sitafloxacin: new trials by email Literature Review of sitafloxacin trials Research Report on sitafloxacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultra-Short Regimen for Elderly DS-TB Bedaquiline (B), Sitafloxacin (S), Linezolid (L) - Pulmonary Tuberculosis | Phase 3 | Not yet recruiting | Shenzhen Third People's Hospital | 300 | 2025-07-25 | 2025-07-22 |
| A PAN-USR TB Multi-Center Trial Bedaquiline (B), Sitafloxacin (S), Linezolid (L) - Pulmonary Tuberculosis | Phase 3 | Recruiting | Shenzhen Third People's Hospital | 610 | 2025-06-18 | 2025-12-01 |
| Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease Sitafloxacin - Fluoroquinolone, Mycobacterium | Phase 2 | Enrolling by invitation | Beijing Chest Hospital | 12 | 2025-01-28 | 2025-02-05 |
| Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment Sitafloxacin, SMZ/TMP, Rifampin - Tuberculosis, Pulmonary | Phase 3 | Unknown | First Affiliated Hospital of Zhejiang University | 620 | 2022-10-01 | 2022-07-12 |
| A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Sitafloxacin, Moxifloxacin Hydrochloride - COPD Exacerbation Acute | Phase 4 | Completed | Daiichi Sankyo | 140 | 2022-08-10 | 2025-01-09 |
| Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients Sitafloxacin, Ertapenem - Anti-Infective Agents, Urinary, Escherichia Coli Infections | Phase 2 / Phase 3 | Unknown | Khon Kaen University | 30 | 2016-07-01 | 2023-03-08 |
| Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli Sitafloxacin, Ertapenem - Infection Due to Escherichia Coli, Acute Pyelonephritis | Phase 2 | Unknown | Mahidol University | 96 | 2012-11-01 | 2015-09-02 |
Tuberculosis, Pulmonary (3) · Escherichia coli Infections (2) · Klebsiella Infections (1) · Mycobacterium Infections (1) · Mycobacterium Infections, Nontuberculous (1) · Pulmonary Disease, Chronic Obstructive (1) · Urinary Tract Infections (1)
Shenzhen Third People's Hospital (2) · Beijing Chest Hospital (1) · Daiichi Sankyo (1) · First Affiliated Hospital of Zhejiang University (1) · Khon Kaen University (1) · Mahidol University (1)
China (3) · Thailand (2)
PMID 36808186, PMID 26038418, PMID 26104205, PMID 36053506, PMID 36546625, PMID 37567554, PMID 37980911